Entera Bio

Developing parathyroid hormone for hypoparathyroidism, osteoporosis and bone healing

placeJerusalem, Jerusalem District, Israel calendar_todayFounded 2010 groups21 employees language enterabio.com

Registered entities

Innovation

16 patent families (5 granted) — focus: Human necessities; filing pace accelerating. Cited 1,747 times.

YearFilings
20153
20165
20172
20183
20193
20203
20212
20223
20239
20246
20259
20265

Social engagement

Social engagement: 2K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Bank & private debt150%

Recent activity

29 May 2026
Event
2025 Interdisciplinary Symposium on Osteoporosis (ISO2025)
10 May 2026
Event
ASBMR White Sneakers Challenge
14 Apr 2026
Event
Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613
Coming soon